Related content

PEG-asparaginase (Oncaspar) 2500 U/m BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols

By Müller Hans-Joachim   Beier Rita   da Palma João   Lanvers Claudia   Ahlke Elvira   von Schütz Volker   Gunkel Martin   Horn Alexander   Schrappe Martin   Henze Günter   Kranz Karen   Boos Joachim  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 149-154

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumors

By Rockwell Sara   Liu Yanfeng   Seow Helen A.   Ishiguro Kimiko   Baumann Raymond P.   Penketh Philip G.   Shyam Krishnamurthy   Akintujoye Oluwatoyin M.   Glazer Peter M.   Sartorelli Alan C.  

International Journal of Radiation Biology, Vol. 88, Iss. 3, 2012-03 ,pp. : 277-285

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States

By  

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 713-720

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of Gefitinib for Treatment of Refractory Solid Tumors and Central Nervous System Malignancies in Pediatric Patients

By Freeman Burgess   Daw Najat   Geyer J.   Furman Wayne   Stewart Clinton  

Cancer Investigation, Vol. 24, Iss. 3, 2006-05 ,pp. : 310-317

Informa Healthcare

Access to resources Recommend Favorite

Treatment resistance of solid tumors: Role of hypoxia and anemia

By Vaupel Peter   Thews Oliver   Hoeckel Michael  

Medical Oncology, Vol. 18, Iss. 4, 2001-12 ,pp. : 243-259

Humana Press, Inc

Access to resources Recommend Favorite